Alongside IGF1/IGF1R signaling, OPN/CD44 binding activates JAK2 (or FAK)/STAT3 pathways, promoting EMT-associated CSC properties, tumor metastasis, and γ-radiation resistance 28,29. Here, IGF1R is linked to neoplasm.